Drugs for Neglected Diseases initiative
A Computerized System Validation Consultant at DNDi ensures compliance with GxP standards by validating computerized systems used in clinical and laboratory activities. The role involves developing validation strategies, reviewing documentation, and collaborating with cross-functional teams to maintain regulatory compliance.
DNDi (Drugs for Neglected Diseases initiative) is a non-profit research and development organization developing affordable, life-saving medicines for neglected diseases. Since 2003, DNDi has delivered 14 treatments for 6 deadly diseases, working in open partnerships with academia, industry and endemic-country networks to ensure access and public-health impact.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Drugs for Neglected Diseases initiative.
Drugs for Neglected Diseases initiative didn’t post a salary, so this is our estimate from similar listings.